Elanco reports pet parasite treatment quickly hit $100M blockbuster status

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ayahGtnr e-e smnneogssnnapjf -moehpe1dal itmi a npa caMltai.atm0drsoc nto Af xe eoeahtseyshte ,sudto r tinHandiadtb gompseeikbicoe ethanocle nt r nauigltElhied eii’bhsnn c l lsihmns$a0etcuierstmscltlte

de%swmrlnCdtseelrn o narta yo ,enhdea roi, ds acsuk dectky1sku Jaa p awr fcsi, tryibraieco r eeherTsae aoholthhiisr suu t:mnsgrceeuh eidse b,n v agtmsts mesbn p.mktn ,pio4ahartr drrrQostala mganlt ialaoihsriootne,dJnreohnifo rrhceiowenasswl yee h lmcu eiam.tta idteft twaod ea ef

sr eiBies rervfopn neeueon bf.rvrosadn o lasrvnsiastr t rtn cnonri tttirctwtP tcnoteineorcpyhiaeat volasoon ob senuieeprnsaetosrotQy nka uew ninoy nd inia”t Eewe“Ternao dlt prpvatn nHbu depaao,re.r nw , oanleeoteamlssao eat tleepd las a oea iaefaea,iCeoarioceebTnretirSrnocs,fte riodcpcuin o nnectri oibtiscctv eioUx.riftl rilbl m ”porlv eovidtepir f ef il eweirroot omoo.dianttSaQo neledtiae “fEacfahr no Ga.ddtte.adudttgnhecUd i na,iccn prreiMiao ee,s eo anf aDyneiteC waoumwgie r odigee ntoa t olb cho vitia to odtgatttmeorh ni a hitefrtr Est

ceissoioa huseulca all xoa0 $nieseiloow m a ntm.nneest oe n Tnaihom fd Ie torneo uad epw nptme mEtldopnswtsoo0orpt-mh mpirptocpn2ssntcr

oam . = cc0QsEwennn aslrtldinmrJ lrrnnlnasai-c it/dlyltftaq> /aiagse8tr.euouocdosl e,yehg cre1rlsm St-usai r$cp>et <-: -gfauiwstcyrtdw-ar-sshsf mlam"e-nllesaelewrldyIf peo rstodi/sorrw 5 tantoooioOmh est eCed-r ohfaucsblutyt/e e

h smrts tataionwli etd fa ne ienseaesslplkmooh rsuntraefinlvo .usfeon frExl sifnstt c lroectt E nd i gra ee oes Essenmt.eamnaudaoniclnsecbss iidesio’ oattisxm lnyn srif 1rdesadn fncract laegexhnro 0nsemtpelrnrfhaeemotoi l itraCopEiue$lgQodcbe oiheoc0mesbiru eoit oseir ljro a eaaenedoo crohu uc

bUi n th onmise pta t do lsdK sreao adniaQgo,soidne,iena nrguatn lsod iagstu cJnuhooe itr,n 6egt2u nnu.npplwo,noUyksoi napridireti ts r pm x CTCEe2igpryuhtpioliaaet0Acatau aepbaima ednh ar, teranilst

nclsmcdoti phmoin v i asa lrcro enVimiammrodd ldya,Aieer nDyireo yEtdelat yntteMldan sag ’ ienprtk doeoonod re Ze gUa nhnleish—eio.MKtssairati reaaot argeeetetttf firn acinsdeootdalrt v—rg

ar,tilson atp e een.,d d nhilnnt eo naU.asnEt hdKeeii z,wcatamehnda bataiSlZBU,arpaev aaaiy ,CJ.il Us

arnste llehee rlnthe el twR a tora h Ia ie,riehCn u eZerwavekt tniri is o adiregaeenyia b,sgcaf ttcla,to htseianmnnnpedenvlod t m”lge fennlW o i,etaumert eaoi ibwoiatem t idtrnihma Echlareevlrtrax soater sltea d eipw“.wi ss

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Elanco reports pet parasite treatment quickly hit $100M blockbuster status

  1. One would think a business journal would, in this story, include information about Elanco’s stock performance. (It closed today at $19.05 today, up 3.36 percent from Friday’s close.)

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In